GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Gross-Profit-to-Asset %

Universal Vision Biotechnology Co (ROCO:3218) Gross-Profit-to-Asset % : 46.34% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Universal Vision Biotechnology Co's annualized Gross Profit for the quarter that ended in Dec. 2023 was NT$2,310 Mil. Universal Vision Biotechnology Co's average Total Assets over the quarter that ended in Dec. 2023 was NT$4,986 Mil. Therefore, Universal Vision Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 46.34%.


Universal Vision Biotechnology Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Universal Vision Biotechnology Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Gross-Profit-to-Asset % Chart

Universal Vision Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.45 43.57 47.30 51.84 50.82

Universal Vision Biotechnology Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.39 53.89 49.24 51.26 46.34

Competitive Comparison of Universal Vision Biotechnology Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Universal Vision Biotechnology Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Vision Biotechnology Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Vision Biotechnology Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Universal Vision Biotechnology Co's Gross-Profit-to-Asset % falls into.



Universal Vision Biotechnology Co Gross-Profit-to-Asset % Calculation

Universal Vision Biotechnology Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2448.37/( (4505.775+5130.584)/ 2 )
=2448.37/4818.1795
=50.82 %

Universal Vision Biotechnology Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=2310.408/( (4840.562+5130.584)/ 2 )
=2310.408/4985.573
=46.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Universal Vision Biotechnology Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co (ROCO:3218) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines